Location History:
- 46 Stockholm, SE (2010)
- Stockholm, SE (2006 - 2014)
Company Filing History:
2 out of 4 
1 out of 38 
1 out of 55 Years Active: 2006-2014
Title: Margit Pelcman: Innovator in Pharmaceutical Composition
Introduction
Margit Pelcman is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are therapeutically active in the central nervous system. With a total of five patents to her name, her work focuses on addressing serotonin-related diseases.
Latest Patents
One of her latest patents is a pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate. This invention relates to a process for preparing compounds that are therapeutically active in the central nervous system. The patent outlines the use of these compounds to manufacture a medicament for treating serotonin-related disorders. Another significant patent involves (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and its salts, which also focuses on the preparation of therapeutically active compounds for similar medical applications.
Career Highlights
Margit has worked with Biovitrum AB, a prominent company in the pharmaceutical industry. Her experience in this organization has contributed to her expertise in developing innovative solutions for medical challenges.
Collaborations
Throughout her career, Margit has collaborated with notable professionals, including Magnus Cernerud and Alexander Paptchikhine. These collaborations have likely enriched her research and development efforts.
Conclusion
Margit Pelcman stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative treatments for serotonin-related diseases. Her contributions through her patents reflect her commitment to advancing medical science.